Replies to post #18287 on Cytodyn Inc (CYDY)

[Saltz]

There are a few investors here that have lost faith in managements ability to move Pro-140 across the finish line because of past delays. They feel it will be a slow drain and the science will be tossed in a ditch. Consequently they have turned negative. I’m the first to be disappointed in the length of time it has taken to progress to this point. However much more important is the reality of why it has taken this long, where we are right now, and what we can expect in 2018. We are not being led blindly by incompetent management, quite the contrary. I’m with you Inoviorulez.

[pearsby09]

What makes Cytodyn unique based on all other HIV medicines currently approved and those approved one day ago is that Pro-140 has no side effects. A second benefit would be that Pro-140 doesn't show to develop drug resistance after a patient has taken it for a long time. These 2 items are key advantages over other competitors. I fail to understand why Amatueur can't see this concept after I have repeatedly explained this to him.

I have to reply to this. The verdict on PRO 140 is NOT out yet as to safety,AE's/Efficacy/resistance. Secondly, I'll bet the farm that PRO 140 will not have ZERO side effects as you suggest in one of your posts. If approved, I Guarantee you their labeling will have it's fair share of side effects and safety concerns..it will not be a clean label. Thirdly, you make a sophomoric remark about a product being new to the market, yet we have one not even close to market yet with N<50 vs. 1000's of patient exposure hours current HAART..During the trials and post market real patient exposure. Before you call someone out, perhaps you should ascertain the entire profile and lack of profile, regarding, Rookie 140.